Nevro Receives Two Patents for Spinal Cord Stimulation Device
Nevro today announced that it received two patents for its Senza High-Frequency Spinal Cord Stimulation System, a device aimed at patients with chronic pain.
The first patent concerns the device's methods for delivering pulsed electrical signals to the epidural space of the spinal cord to relieve a patient's chronic leg or back pain without creating paresthesia. An additional patent includes claims that correspond to many of the method claims of the first patent.
The patents represent an "important milestone" in the development of spinal cord stimulation technology, said Michael DeMane, Nevro president and CEO.
Related Articles on Pain Management:Growing a Comprehensive Pain Management Practice: Q&A With Pain Specialists of Charleston
Greenwich Hospital Physicians Honored for Pain Management
Low-Dose Diclofenac Reduces Post-Op Pain in Phase 3 Trial
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- HSHS Medical, Sangamon Associated Anesthesiologists Collaborate for Enhanced Surgical Services in Illinois
- New England Baptist Outpatient Care Center Goes Live With Anesthesia Touch
- Mexican Company Acquires Assets of Medical Imaging System Maker Naviscan
- MedVenture Names Mitch Moeller CEO
- Santa Ynez Tribal Health Clinic Earns AAAHC Accreditation